154 related articles for article (PubMed ID: 10224283)
1. The dual nature of specific immunological activity of tumor-derived gp96 preparations.
Chandawarkar RY; Wagh MS; Srivastava PK
J Exp Med; 1999 May; 189(9):1437-42. PubMed ID: 10224283
[TBL] [Abstract][Full Text] [Related]
2. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.
Udono H; Levey DL; Srivastava PK
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3077-81. PubMed ID: 7909157
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis.
Chandawarkar RY; Wagh MS; Kovalchin JT; Srivastava P
Int Immunol; 2004 Apr; 16(4):615-24. PubMed ID: 15039392
[TBL] [Abstract][Full Text] [Related]
4. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory.
Dai J; Liu B; Caudill MM; Zheng H; Qiao Y; Podack ER; Li Z
Cancer Immun; 2003 Jan; 3():1. PubMed ID: 12747743
[TBL] [Abstract][Full Text] [Related]
5. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
Arnold D; Faath S; Rammensee H; Schild H
J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
[TBL] [Abstract][Full Text] [Related]
6. Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96.
Janetzki S; Blachere NE; Srivastava PK
J Immunother; 1998 Jul; 21(4):269-76. PubMed ID: 9672848
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
[TBL] [Abstract][Full Text] [Related]
8. Treg suppress CTL responses upon immunization with HSP gp96.
Liu Z; Li X; Qiu L; Zhang X; Chen L; Cao S; Wang F; Meng S
Eur J Immunol; 2009 Nov; 39(11):3110-20. PubMed ID: 19839010
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor MHC class Ia-unrestricted CD8 T cell cytotoxicity elicited by the heat shock protein gp96.
Goyos A; Cohen N; Gantress J; Robert J
Eur J Immunol; 2004 Sep; 34(9):2449-58. PubMed ID: 15307177
[TBL] [Abstract][Full Text] [Related]
11. Association of peptides with heat shock protein gp96 occurs in vivo and not after cell lysis.
Ménoret A; Peng P; Srivastava PK
Biochem Biophys Res Commun; 1999 Sep; 262(3):813-8. PubMed ID: 10471407
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.
Udono H; Srivastava PK
J Immunol; 1994 Jun; 152(11):5398-403. PubMed ID: 8189059
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice.
Li HT; Yan JB; Li J; Zhou MH; Zhu XD; Zhang YX; Tien P
World J Gastroenterol; 2005 May; 11(19):2858-63. PubMed ID: 15902719
[TBL] [Abstract][Full Text] [Related]
14. Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.
Arnold D; Wahl C; Faath S; Rammensee HG; Schild H
J Exp Med; 1997 Aug; 186(3):461-6. PubMed ID: 9236199
[TBL] [Abstract][Full Text] [Related]
15. Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model.
Yedavelli SP; Guo L; Daou ME; Srivastava PK; Mittelman A; Tiwari RK
Int J Mol Med; 1999 Sep; 4(3):243-8. PubMed ID: 10425272
[TBL] [Abstract][Full Text] [Related]
16. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70.
Robert J; Ménoret A; Basu S; Cohen N; Srivastava PR
Eur J Immunol; 2001 Jan; 31(1):186-95. PubMed ID: 11265634
[TBL] [Abstract][Full Text] [Related]
17. [Induction of anti-tumor immunity by HSP gp96-peptide complexes].
Zhang TY; Niu JX; Lin L; Huang XC; Gu JY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):17-20. PubMed ID: 15629075
[TBL] [Abstract][Full Text] [Related]
18. One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
Arnold-Schild D; Kleist C; Welschof M; Opelz G; Rammensee HG; Schild H; Terness P
Cancer Res; 2000 Aug; 60(15):4175-8. PubMed ID: 10945626
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation.
Lammert E; Arnold D; Rammensee HG; Schild H
Eur J Immunol; 1996 Apr; 26(4):875-9. PubMed ID: 8625982
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein gp96 and cancer immunotherapy.
Peibin Y; Shude Y; Changzhi H
Chin Med Sci J; 2002 Dec; 17(4):251-6. PubMed ID: 12901515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
